Item 8.01 Other Events

On September 26, 2022, the Company issued a press release announcing a strategic realignment and forward focus on treating CNS disorders. The press release is filed as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits

The following exhibits are filed with this report:





Exhibit No.   Description

99.1            Press Release announcing "Lipocine Announces Strategic Realignment
              and Forward Focus on Treating CNS Disorders"

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses